Salvatore Piscuoglio

12.2k total citations · 3 hit papers
133 papers, 5.3k citations indexed

About

Salvatore Piscuoglio is a scholar working on Cancer Research, Oncology and Molecular Biology. According to data from OpenAlex, Salvatore Piscuoglio has authored 133 papers receiving a total of 5.3k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Cancer Research, 54 papers in Oncology and 50 papers in Molecular Biology. Recurrent topics in Salvatore Piscuoglio's work include Cancer Genomics and Diagnostics (49 papers), Genetic factors in colorectal cancer (19 papers) and Breast Lesions and Carcinomas (18 papers). Salvatore Piscuoglio is often cited by papers focused on Cancer Genomics and Diagnostics (49 papers), Genetic factors in colorectal cancer (19 papers) and Breast Lesions and Carcinomas (18 papers). Salvatore Piscuoglio collaborates with scholars based in Switzerland, United States and Italy. Salvatore Piscuoglio's co-authors include Charlotte K.Y. Ng, Britta Weigelt, Jorge S. Reis‐Filho, Luigi Terracciano, Markus H. Heim, Matthias S. Matter, Luciano G. Martelotto, Mairene Coto‐Llerena, Luca Quagliata and Caner Ercan and has published in prestigious journals such as Nature, Cell and Nucleic Acids Research.

In The Last Decade

Salvatore Piscuoglio

130 papers receiving 5.2k citations

Hit Papers

YAP/TAZ and ATF4 drive resistance to Sorafenib in hepa... 2018 2026 2020 2023 2021 2018 2023 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. YAP/TAZ and ATF4 drive resistance to Sorafenib in hepatocellular carcinoma by preventing ferroptosis
    2021 348 citations Ravi Kiran Reddy Kalathur, Mairene Coto‐Llerena et al. profile →
  2. Organoid Models of Human Liver Cancers Derived from Tumor Needle Biopsies
    2018 339 citations Sandro Nuciforo, Matthias S. Matter et al. profile →
  3. Arginine reprograms metabolism in liver cancer via RBM39
    2023 145 citations Marco Colombi, Eva Dazert et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Salvatore Piscuoglio Switzerland 39 2.7k 2.5k 1.7k 1.0k 861 133 5.3k
Charlotte K.Y. Ng Switzerland 42 3.5k 1.3× 2.4k 0.9× 2.6k 1.5× 1.5k 1.4× 1.4k 1.6× 120 6.5k
David S. Rickman United States 34 1.6k 0.6× 2.8k 1.1× 1.4k 0.8× 1.6k 1.5× 855 1.0× 63 5.6k
Kay Savage United Kingdom 42 2.1k 0.8× 2.8k 1.1× 2.6k 1.5× 647 0.6× 1.0k 1.2× 66 5.7k
Gorana Tomasic France 33 1.3k 0.5× 1.7k 0.7× 4.4k 2.6× 1.4k 1.3× 1.3k 1.5× 63 6.0k
Eric A. Collisson United States 30 2.1k 0.8× 2.2k 0.9× 2.9k 1.7× 1.0k 1.0× 662 0.8× 81 5.2k
Tetsunari Oyama Japan 43 1.7k 0.6× 2.9k 1.2× 2.8k 1.6× 1.0k 1.0× 900 1.0× 281 7.2k
Anthony N. Karnezis United States 41 1.5k 0.6× 4.2k 1.7× 2.4k 1.4× 750 0.7× 1.1k 1.3× 90 7.9k
Gaia Schiavon United Kingdom 28 1.9k 0.7× 1.5k 0.6× 2.5k 1.5× 1.7k 1.6× 644 0.7× 105 4.6k
Christophe Rosty Australia 42 1.6k 0.6× 2.7k 1.1× 4.4k 2.6× 1.4k 1.3× 2.3k 2.7× 134 7.2k
Beatríz Bellosillo Spain 45 1.2k 0.5× 2.9k 1.2× 2.3k 1.3× 980 0.9× 2.2k 2.6× 231 7.6k

Countries citing papers authored by Salvatore Piscuoglio

Since Specialization
Citations

This map shows the geographic impact of Salvatore Piscuoglio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Salvatore Piscuoglio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Salvatore Piscuoglio more than expected).

Fields of papers citing papers by Salvatore Piscuoglio

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Salvatore Piscuoglio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Salvatore Piscuoglio. The network helps show where Salvatore Piscuoglio may publish in the future.

Co-authorship network of co-authors of Salvatore Piscuoglio

This figure shows the co-authorship network connecting the top 25 collaborators of Salvatore Piscuoglio. A scholar is included among the top collaborators of Salvatore Piscuoglio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Salvatore Piscuoglio. Salvatore Piscuoglio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Akyürek, Nalân, Spasenija Savic Prince, Kirsten D. Mertz, et al.. (2024). Tracing Tumor Heterogeneity of Pleomorphic Carcinoma of the Lung. Journal of Thoracic Oncology. 19(9). 1284–1296. 2 indexed citations
2.
Handler, Kristina, Karsten Bach, Costanza Borrelli, et al.. (2023). Fragment-sequencing unveils local tissue microenvironments at single-cell resolution. Nature Communications. 14(1). 7775–7775. 5 indexed citations
3.
Simó‐Riudalbas, Laia, Sandra Offner, Evarist Planet, et al.. (2022). Transposon-activated POU5F1B promotes colorectal cancer growth and metastasis. Nature Communications. 13(1). 4913–4913. 14 indexed citations
4.
Ng, Charlotte K.Y., Eva Dazert, Mairene Coto‐Llerena, et al.. (2022). Integrative proteogenomic characterization of hepatocellular carcinoma across etiologies and stages. Nature Communications. 13(1). 2436–2436. 88 indexed citations
5.
Srivatsa, Sumana, Hesam Montazeri, Mairene Coto‐Llerena, et al.. (2022). Discovery of synthetic lethal interactions from large-scale pan-cancer perturbation screens. Nature Communications. 13(1). 7748–7748. 16 indexed citations
6.
Gallon, John, Mairene Coto‐Llerena, Caner Ercan, et al.. (2021). Epigenetic priming in chronic liver disease impacts the transcriptional and genetic landscapes of hepatocellular carcinoma. Molecular Oncology. 16(3). 665–682. 7 indexed citations
7.
Montazeri, Hesam, Mairene Coto‐Llerena, Ehsan Zangene, et al.. (2021). Systematic identification of novel cancer genes through analysis of deep shRNA perturbation screens. Nucleic Acids Research. 49(15). 8488–8504. 6 indexed citations
8.
Moukarzel, Lea A., Lorenzo Ferrando, Arnaud Da Cruz Paula, et al.. (2020). The genetic landscape of metaplastic breast cancers and uterine carcinosarcomas. Molecular Oncology. 15(4). 1024–1039. 19 indexed citations
9.
Saxena, Meera, Ravi Kiran Reddy Kalathur, Natalia Rubinstein, et al.. (2020). A Pygopus 2-Histone Interaction Is Critical for Cancer Cell Dedifferentiation and Progression in Malignant Breast Cancer. Cancer Research. 80(17). 3631–3648. 12 indexed citations
10.
Ghosh, Souvik, Joao C. Guimaraes, Manuela Lanzafame, et al.. (2020). Prevention of dsRNA‐induced interferon signaling by AGO1x is linked to breast cancer cell proliferation. The EMBO Journal. 39(18). e103922–e103922. 21 indexed citations
11.
Zeng, Jennifer, Salvatore Piscuoglio, Maria A. Friedlander, et al.. (2019). Hormone receptor and HER2 assessment in breast carcinoma metastatic to bone: A comparison between FNA cell blocks and decalcified core needle biopsies. Cancer Cytopathology. 128(2). 133–145. 7 indexed citations
12.
Zoni, Eugenio, Charlotte K.Y. Ng, Salvatore Piscuoglio, et al.. (2019). Therapeutic Targeting of CD146/MCAM Reduces Bone Metastasis in Prostate Cancer. Molecular Cancer Research. 17(5). 1049–1062. 21 indexed citations
13.
Zeindler, Jasmin, Raoul A. Droeser, Silvio Däster, et al.. (2019). Infiltration by myeloperoxidase-positive neutrophils is an independent prognostic factor in breast cancer. Breast Cancer Research and Treatment. 177(3). 581–589. 41 indexed citations
14.
Lee, Ju Youn, Michail Schizas, Felipe C. Geyer, et al.. (2018). Lobular Carcinomas In Situ Display Intralesion Genetic Heterogeneity and Clonal Evolution in the Progression to Invasive Lobular Carcinoma. Clinical Cancer Research. 25(2). 674–686. 39 indexed citations
15.
Montagna, Giacomo, Charlotte K.Y. Ng, Tatjana Vlajnic, et al.. (2018). Fibroepithelial Breast Lesion: When Sequencing Can Help to Make a Clinical Decision. A Case Report. Clinical Breast Cancer. 19(1). e1–e6. 4 indexed citations
16.
Garofoli, Andrea, Nadia Tosti, Manuela Lanzafame, et al.. (2018). Diagnostic Targeted Sequencing Panel for Hepatocellular Carcinoma Genomic Screening. Journal of Molecular Diagnostics. 20(6). 836–848. 13 indexed citations
17.
Ng, Charlotte K.Y., François‐Clément Bidard, Salvatore Piscuoglio, et al.. (2017). Genetic Heterogeneity in Therapy-Naïve Synchronous Primary Breast Cancers and Their Metastases. Clinical Cancer Research. 23(15). 4402–4415. 83 indexed citations
18.
Ng, Charlotte K.Y., Salvatore Piscuoglio, Felipe C. Geyer, et al.. (2017). The Landscape of Somatic Genetic Alterations in Metaplastic Breast Carcinomas. Clinical Cancer Research. 23(14). 3859–3870. 110 indexed citations
19.
Bidard, François‐Clément, Charlotte K.Y. Ng, Paul Cottu, et al.. (2015). Response to dual HER2 blockade in a patient with HER3-mutant metastatic breast cancer. Annals of Oncology. 26(8). 1704–1709. 20 indexed citations
20.
Kishore, Shivendra, Salvatore Piscuoglio, Michal Kováč, et al.. (2013). 3′-UTR Poly(T/U) Tract Deletions and Altered Expression of EWSR1 Are a Hallmark of Mismatch Repair–Deficient Cancers. Cancer Research. 74(1). 224–234. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Charlotte K.Y. Ng Breakdown of academic impact, for papers by David S. Rickman Breakdown of academic impact, for papers by Kay Savage Breakdown of academic impact, for papers by Gorana Tomasic Breakdown of academic impact, for papers by Eric A. Collisson Breakdown of academic impact, for papers by Tetsunari Oyama Breakdown of academic impact, for papers by Anthony N. Karnezis Breakdown of academic impact, for papers by Gaia Schiavon Breakdown of academic impact, for papers by Christophe Rosty Breakdown of academic impact, for papers by Beatríz Bellosillo
Rankless by CCL
2026